Roivant Sciences (ROIV) logo

Roivant Sciences (ROIV) insider trading in the last 6 months

3 insiders sold $176M. No buys.

Filings: 20, in the last 6 months
Quality Score: 13, Above Average

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 20 tradesSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

SellMayukh Sukhatme$6.4MPresident & CIOat $37.17 on Aug 19, filed Aug 21
SellMayukh Sukhatme$5.3MPresident & CIOat $36.48 on Aug 21, filed Aug 21
SellMayukh Sukhatme$653KPresident & CIOat $37.30 on Aug 20, filed Aug 21

From SEC Form 4s, the newest filed Aug 21, 2026 · Insiders have 2 business days to file a trade

17 more filings on ROIV in the last 6 months, for Pro members. See them free →

Pro members see every filing on ROIV with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Roivant Sciences

Insider trades by person

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about ROIV's insider trades

As of Nov 10, 2026: Roivant Sciences (ROIV) has 20 insider filings on record in the last 6 months, the newest filed Aug 21, 2026. Its Quality Score is 13 (Above Average). Scores as of 10:56 PM ET, 15 minutes behind.

Are ROIV insiders buying or selling?

3 insiders sold $176M across 20 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Mayukh Sukhatme, President & CIO, sold $6.4M on Aug 19, 2026.

Who are ROIV's biggest insider sellers?

By the dollars of their sales in the last 6 months: Mayukh Sukhatme (President & CIO), 9 sales; Keith S. Manchester (Director), 6 sales; Daniel Allen Gold (Director), 5 sales.

When did an ROIV insider last buy?

No ROIV insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Mayukh Sukhatme on Aug 19, 2026.

Roivant Sciences's page has its Quality Score, its chart, and its earnings. More in Healthcare and Pharma.

Every insider trade, with its stock's score.

Real-time prices, every Form 4 on every stock with its Quality Score, sorting, filters, and optional alerts when the people you follow file.

See the last 30 days of insider trades

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Shares insiders bought or sold themselves, as filed on Form 4. Grants, option exercises, shares withheld for tax, and 10b5-1 plan sales are left out.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.